Natixis Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$234M Sell
506,804
-5,109
-1% -$2.58M 0.33% 69
2025
Q4
$290M Buy
511,913
+39,563
+8% +$21.1M 0.41% 38
2025
Q3
$211M Sell
472,350
-81,894
-15% -$39.3M 0.31% 63
2025
Q2
$301M Buy
554,244
+33,160
+6% +$17.3M 0.48% 33
2025
Q1
$258M Buy
521,084
+1,082
+0.2% +$598K 0.48% 35
2024
Q4
$271M Sell
520,002
-6,807
-1% -$3.55M 0.51% 31
2024
Q3
$259M Buy
526,809
+11,381
+2% +$5.3M 0.5% 32
2024
Q2
$229M Sell
515,428
-23,205
-4% -$9.24M 0.5% 33
2024
Q1
$215M Buy
538,633
+869
+0.2% +$328K 0.49% 35
2023
Q4
$181M Buy
537,764
+39,270
+8% +$11.7M 0.48% 40
2023
Q3
$146M Sell
498,494
-530
-0.1% -$166K 0.45% 47
2023
Q2
$171M Buy
499,024
+74,395
+18% +$22.5M 0.53% 29
2023
Q1
$108M Sell
424,629
-47,811
-10% -$11.8M 0.37% 62
2022
Q4
$125M Buy
472,440
+191,081
+68% +$46.6M 0.47% 38
2022
Q3
$52.7M Buy
281,359
+36,334
+15% +$7.8M 0.22% 117
2022
Q2
$49.2M Sell
245,025
-6,166
-2% -$1.45M 0.22% 117
2022
Q1
$75.8M Sell
251,191
-2,642
-1% -$772K 0.29% 81
2021
Q4
$91.2M Sell
253,833
-61,422
-19% -$21.1M 0.35% 56
2021
Q3
$104M Buy
315,255
+100,926
+47% +$33.9M 0.43% 49
2021
Q2
$65.7M Buy
214,329
+5,304
+3% +$1.49M 0.31% 63
2021
Q1
$51.5M Sell
209,025
-4,560
-2% -$1.15M 0.27% 80
2020
Q4
$58.2M Sell
213,585
-16,677
-7% -$4.14M 0.34% 62
2020
Q3
$54.5M Buy
230,262
+7,914
+4% +$1.78M 0.34% 59
2020
Q2
$42.2M Buy
222,348
+139,710
+169% +$25M 0.28% 73
2020
Q1
$13.6M Sell
82,638
-35,079
-30% -$6.42M 0.11% 210
2019
Q4
$23.2M Buy
117,717
+6,063
+5% +$1.14M 0.16% 145
2019
Q3
$20.1M Buy
111,654
+15,882
+17% +$2.75M 0.16% 156
2019
Q2
$16.7M Sell
95,772
-2,586
-3% -$443K 0.14% 168
2019
Q1
$18.7M Buy
98,358
+7,185
+8% +$1.28M 0.16% 144
2018
Q4
$14.6M Buy
91,173
+3,561
+4% +$603K 0.14% 158
2018
Q3
$16.8M Buy
87,612
+6,945
+9% +$1.23M 0.15% 157
2018
Q2
$12.9M Buy
+80,667
New +$12.3M 0.12% 186
2014
Q2
Sell
-34,839
Closed -$1.7M 1317
2014
Q1
$1.7M Buy
+34,839
New +$1.64M 0.03% 656
2013
Q3
Sell
-12,393
Closed -$697K 1128
2013
Q2
$697K Buy
+12,393
New +$683K 0.01% 746

Other funds holding ISRG

Natixis Advisors's ISRG Position: Q1 2026 in Review

Natixis Advisors reduced its Intuitive Surgical (ISRG) stake by 1% in Q1 2026, selling an estimated $2.58M and leaving 506,804 shares worth $234M. The position accounts for 0.33% of the portfolio, ranked #69.

Natixis Advisors first reported a position in ISRG in Q2 2013 and has held it in 34 quarters since. The position peaked at $301M in Q2 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Natixis Advisors held 506,804 shares of Intuitive Surgical worth $234M as of Q1 2026.
  • Natixis Advisors sold 5,109 Intuitive Surgical shares in Q1 2026, an estimated $2.58M.
  • Intuitive Surgical made up 0.33% of Natixis Advisors's portfolio in Q1 2026, its #69 holding.
  • Natixis Advisors first reported a position in Intuitive Surgical in Q2 2013 and has held it in 34 quarters since.
  • Natixis Advisors's Intuitive Surgical position peaked at $301M in Q2 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.